On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Epigenetically mediated gene silencing
- Process of DNA methylation
- Altered chromatin status in cancer
- Familial cancer genes
- Chromatin composition
- Screening the cancer genome
- Vogalstein paradigm
- Re-activated hypermethylated genes
- Hypothesis-early stage epigenetic gene silencing
- Epigenetic & genetic interaction in tumorigenesis
- sFRP genes - what are they?
- SFRP hypermethylation and CRC progression
- Epigenetic silencing of SFRPs in CRC
- Concept of cancer pathway addiction
- Collaboration in early colon tumorigenesis
- Heretical hypothesis
- Re-activated hypermethylated genes
- Screening the cancer genome
- HIC-1 is a candidate tumor suppressor gene
- HIC-1 hypermethylation in human cancer
- Targeted disruption of mouse Hic-1 gene
- Hic-1 as a tumor suppressor in mouse models
- Epigenetic and genetic interactions
- The full activities if HIC-1
- Properties of SIRT1
- Paradigm summary for HIC-1 P53 interaction
- Hypothesis review
- Translational implications
Topics Covered
- Introduction to epigenetic changes in cancer
- defining the process of promoter DNA hypermethylation as a constituent of a broad range of chromatin abnormalities in cancer
- defining the genes aberrantly silenced in cancer including approaches being used to screen the cancer genome for such genes
- defining what is known about the interaction of DNA methylation and chromatin modifications for initiating and maintaining gene silencing in cancer
- outlining the position of aberrant gene silencing in tumor progression and particularly highlighting the key role these changes may play for the earliest steps in tumorigenesis
- defining the potential for using DNA hypermethylated gene promoter sequences as molecular markers for cancer risk assessment, early diagnosis and prognosis
- discussing the possibilities for targeting reversal of gene silencing as a prevention and therapeutic strategy for cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Baylin, S. (2007, October 1). Epigenetically mediated gene silencing: a companion to genetic alterations in driving tumorigenesis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/VRTX2257.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Stephen Baylin has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Epigenetically mediated gene silencing: a companion to genetic alterations in driving tumorigenesis
A selection of talks on Biochemistry
Hide